LINC00637

Across TCGA pan-cancer cohorts, LINC00637 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated LINC00637 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC00637 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC00637 expression acts as an unfavorable survival marker, although some lineages such as LUAD and ACC show a favorable association.

LUAD, SKCM, and ACC are the cancer types where LINC00637 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	III,IV	0.495	0.274	.005	42	view →
SKCM	OS	Quartile	III,IV	0.704	0.838	.003	33	view →
ACC	DFS	Quartile	III,IV	0.679	0.126	.016	27	view →
KIRP	OS	Quartile	All	0.904	0.988	.006	19	view →
HNSC	DFS	Median	All	0.684	0.568	.006	18	view →
UCS	DFS	Median	IV	0.909	0.416	.008	16	view →
THCA	DFS	Tertile	IV	0.498	0.865	.011	16	view →
STAD	OS	Median	All	0.741	0.588	.002	10	view →
CESC	OS	Median	II,III,IV	0.834	0.674	.026	8	view →
ESCA	OS	Median	II,III,IV	0.618	0.409	.004	7	view →
READ	OS	Median	All	0.932	0.449	.009	7	view →
DLBC	DFS	Median	All	1.000	0.668	.034	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

LINC00637–LUAD (OS)

Open the LUAD breakdown →